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SUMMARY
The age distribution of inﬂuenza A(H5N1) cases reported during 2006–2013 varied substantially
between countries. As well as underlying demographic proﬁles, it is possible that cross-immunity
contributed to the age distribution of reported cases: seasonal inﬂuenza A(H1N1) and avian
inﬂuenza A(H5N1) share the same neuraminidase subtype, N1. Using a mechanistic model, we
measured the extent to which population age distribution and heterosubtypic cross-immunity
could explain the observed age patterns in Cambodia, China, Egypt, Indonesia and Vietnam.
Our results support experimental evidence that prior infection with H1N1 confers partial
cross-immunity to H5N1, and suggest that more than 50% of spillover events did not lead to
reported cases of infection as a result. We also identiﬁed age groups that have additional risk
factors for inﬂuenza A(H5N1) not captured by demography or infection history.
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INTRODUCTION
The potential for highly pathogenic infections to
transmit from animals to humans is a major public
health concern [1, 2]. Between 1 January 2006 and 1
December 2013, a total of 500 conﬁrmed inﬂuenza
A(H5N1) cases were reported to the World Health
Organization. Of these, 467 cases came from ﬁve
countries: Cambodia, China, Egypt, Indonesia and
Vietnam.
The age distribution of cases varied substantially
between countries [3–5]. In most countries, there
were a disproportionally high number of cases of
inﬂuenza A(H5N1) in the <5 years age group, and
another peak in the 25–35 years age group (Fig. 1).
If reported spillover events occurred at an equal rate
across all ages, we would expect the size of a particu-
lar age group to be predictive of the number of
reported infections in that group. Hence the points
in Figure 2a would form horizontal lines. However,
it is possible that cross-immunity also contributed to
the age distribution of reported cases. Inﬂuenza A
(H1N1) and A(H5N1) viruses share the same neura-
minidase subtype, N1, and there is evidence that
H1N1 neuraminidase antibodies cross-react with
H5N1 viruses [6–8].
To establish whether demographic proﬁles and het-
erosubtypic cross-immunity could explain observed
patterns of infection, we used a mechanistic model
to measure how spillover risk combines with cross-
immunity from prior infection in the host population.
We also analysed the relationship between exposure
and infection, and examined the extent to which age-
speciﬁc variation in risk of H5N1 transmission –with
or without additional cross-immunity from H1N1
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infection – could have shaped the observed distribu-
tion of H5N1 infection.
METHODS
We compiled a line list of conﬁrmed cases of inﬂuenza
A(H5N1) reported to the World Health Organization
between 1 January 2006 and 1 December 2013. For
each case we gathered details of location and age of
patient. Demographic data for each country was
obtained from the United Nations Statistics Division
Demographic Statistics database.
We assumed that the number of reported cases in
each age group followed a Poisson distribution. In
our cross-immunity model, the expected number of
cases depended on two things: spillover risk and cross-
immunity from prior exposure to inﬂuenza A(H1N1).
We assumed that the expected number of spillover
events into each age group was equal to the popu-
lation size (in millions) multiplied by a certain par-
ameter. As we were ﬁtting the model to total case
numbers rather than temporal data, this parameter
represented the total per capita number of spillover
events rather than frequency of spillover.
To include cross-immunity, we assumed that the
probability of having not yet been infected with
inﬂuenza A(H1N1) decreased exponentially with
age: the longer an individual is alive, the more oppor-
tunities they have had to become infected [9]. Given
prior infection with H1N1, there was a certain
100
Cambodia
China
Egypt
Indonesia
Vietnam10
1
0·1
0·01
Age group (years)
C
as
es
 p
er
 m
illi
on
0
<5
5–
15
15
–2
5
25
–3
5
35
–6
0
60
–7
5
Fig. 1. Demographic patterns of inﬂuenza A(H5N1)
infection. Points show reported cases per million people,
stratiﬁed by age group.
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Fig. 2. Comparison of reported cases in each country and
model ﬁts. (a–e) Results from model with cross-immunity
only; (f–j) model with cross-immunity and age-dependent
exposure risk. Dots show conﬁrmed H5N1 cases in each
5-year age band; solid blue line shows model estimate;
dashed lines give 95% credible intervals.
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probability that the host will subsequently have cross-
immunity against H5N1. The expected number of
reported H5N1 cases in each group was therefore
equal to the number of spillover events multiplied by
the number of people that have no cross-immunity
from prior H1N1 infection. Hence our model for a
speciﬁc age group was:
expected no. cases in age group a = nxe−βa,
where a was the midpoint of the age group (i.e. 2·5 for
the 0–5 years group), β was the average annual prob-
ability of gaining cross-immunity to H5N1 as a result
of H1N1 infection, n was the number of individuals
(in millions) and x was the number of spillover events
per million people. There were six parameters in the
model: x for each of the ﬁve countries, and β. We esti-
mated these parameters using Markov chain Monte
Carlo.
We also considered the possibility that age-speciﬁc
infection patterns could be explained by age-
dependent variation in risk of H5N1 exposure rather
than cross-immunity. There were little data available
on age-dependent patterns of contact with poultry
and potential risk of exposure to H5N1 in the ﬁve
countries we considered. However, one cross-sectional
survey in Cambodia suggested that individuals aged
515 years had a higher H5N1 transmission risk po-
tential than those aged <15 years [10].
To account for possible differences in exposure risk
with age, we incorporated a step function into our
basic spillover model, with different relative risks of
H5N1 exposure for individuals aged <15 and 515
years. We allowed the relative risk to vary for each
country, with the constraint that in Cambodia those
aged 515 years had a larger risk than those aged
<15 years (we imposed no constraints on the relative
risk in other countries). Our model for a speciﬁc age
group was therefore:
expected no. cases in age group a = nxr(a)e−βa,
where r(a) denotes the relative risk of H5N1 exposure
in individuals aged 515 years, with r(a) = 1 if a< 15
and r(a) = r if a515. If we set β = 0, we obtained a
model with age-speciﬁc exposure risk only. In this
model there were 10 parameters to estimate: x and r
for each of the ﬁve countries. If we allow β to vary,
there were 11 parameters to estimate.
Using the above models, we compared four different
combinations of assumptions: no cross-immunity or
age-speciﬁc variation in exposure; cross-immunity
only; age-speciﬁc exposure only; or cross-immunity
and age-speciﬁc exposure.We assessed model perform-
ance using the Bayesian Information Criterion (BIC)
[11]. If L was the maximum likelihood estimate for a
model with p parameters ﬁtted to d data points:
BIC = −2 log(L) + p[log d + log(2π)].
We compared candidate models by calculating ΔBIC,
the difference between the model of interest and the
smallest BIC of all models tested. If ΔBIC > 10 there is
strong evidence against the model with the larger BIC.
If ΔBIC < 2 there is a negligible difference between the
two models [12].
RESULTS
We found that models that included cross-immunity
between inﬂuenza A(H1N1) and A(H5N1) performed
much better than the others we considered (Table 1).
The inclusion of age-speciﬁc inﬂuenza A(H5N1)
exposure risk and cross-immunity produced a better
ﬁt as measured by log-likelihood, but the improvement
in model performance did not provide clear evidence in
favour of additional model complexity: there was
negligible difference in ΔBIC between the two cross-
immunity models. We also considered a model in
which there were three different risk groups: <15, 15–
60, and >60 years. However, even when cross-
immunity is included, these models had less support
than the original model with two risk groups (Table 2).
Our parameter estimates suggest that spillover risk
varied substantially between different countries. In
the two best-performing models, the per capita num-
ber of spillover events was highest in Cambodia and
Egypt, smaller in Indonesia and Vietnam, and lowest
in China (Table 3). In all countries, the estimated
number of spillover events was larger than the number
of reported cases, suggesting that observed disease in-
cidence would have been higher if host populations
did not have pre-existing immunity. When the model
included age-speciﬁc risk of exposure to H5N1 as
well as cross-immunity, there was strong evidence
that the risk was higher in the 515 years age group
in all countries (Table 4). In the best-performing
model, which included both cross-immunity and age-
speciﬁc exposure risk, we estimated that the annual
probability of obtaining protection against H5N1 as
a result of H1N1 infection was 0·06 [95% credible in-
terval (CrI) 0·05–0·07]. In the cross-immunity only
model, it was 0·04 (95% CrI 0·03–0·04).
While the best-ﬁtting models captured the general
trend in reported cases with age, there were some
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discrepancies (Fig. 2). The number of reported H5N1
cases in the <5 years age group in Cambodia (Fig. 2a,
f) andEgypt (Fig. 2c, h)wasmuchhigher thanpredicted
by eithermodel. It appears the surplus ofH5N1 cases in
the 20–40 years age groups in China, Indonesia and
Vietnam could be partly explained by an increased
risk of H5N1 exposure in these age groups (Fig. 2g, i, j).
DISCUSSION
Using a simple mechanistic model, we examined the
age distribution of reported inﬂuenza A(H5N1) cases
in ﬁve countries between 2006 and 2013. Our analysis
produced three key observations. First, much of the
age pattern of infection can be explained through a
combination of ﬁxed spillover risk and age-dependent
cross-immunity. In particular, the model reproduced
the decline in reported cases with age in each country.
Without cross-immunity, model performance was
much worse, suggesting that demography alone can-
not explain the observed age distribution of cases.
Second, there was a trade-off between age-speciﬁc
cross-immunity and per capita spillover risk. Our esti-
mates for spillover risk suggest that more than 50% of
spillover events did not lead to reported infections, be-
cause hosts had partial immunity against H5N1
(Table 3). Such a discrepancy would not be immedi-
ately clear from the raw data presented in Figure 1.
Table 1. Comparison of model performance
Model Description Parameters Log likelihood ΔBIC
1 Demography only 5 −235·9 106·9
2 Age-speciﬁc exposure 10 −219·3 104·3
3 Cross-immunity 6 −177·6 1·5
4 Age-speciﬁc exposure and cross-immunity 11 −161·5 0
BIC, Bayesian Information Criterion.
Table 2. Comparison of model performance when age-speciﬁc exposure is deﬁned using a step function with
two steps (age <15 years/515 years) and three steps (age <15, 15–60, >60 years)
Model Description Parameters Log likelihood ΔBIC
1 Demography only 5 −235·9 106·9
2 Age-speciﬁc exposure (2 steps) 10 −219·3 104·3
3 Cross-immunity 6 −177·6 1·5
4 Age-speciﬁc exposure (2 steps) and cross-immunity 11 −161·5 0
5 Age-speciﬁc exposure (3 steps) 15 −211·1 126·4
6 Age-speciﬁc exposure (3 steps) and cross-immunity 16 −159·6 27·0
BIC, Bayesian Information Criterion.
Table 3. Estimated number of spillover events per
million people for each country in the two
best-performing models (3 and 4), and reported
inﬂuenza A(H5N1) cases per million between 2006 and
2013
Country
Estimated
spillover
(model 3)
Estimated
spillover
(model 4)
Reported
cases
Cambodia 4·83 (3·38–6·45) 7·19 (5·07–9·51) 2·35
China 0·08 (0·05–0·11) 0·16 (0·10–0·24) 0·03
Egypt 4·36 (3·55–5·41) 6·99 (5·55–9·34) 2·03
Indonesia 1·36 (1·06–1·69) 2·70 (2·13–3·53) 0·59
Vietnam 0·82 (0·54–1·20) 1·80 (1·11–2·81) 0·34
95% credible intervals are given in parentheses.
Table 4. Estimated relative inﬂuenza A(H5N1)
exposure risk in individuals aged 515 years compared
to <15 years in each country between 2006 and 2013
Country
515 years age group
RR (95% CrI)
Cambodia 1·10 (1·00–1·50)
China 2·76 (2·07–3·43)
Egypt 1·44 (1·08–2·09)
Indonesia 3·03 (2·49–3·66)
Vietnam 5·23 (1·83–6·04)
RR, Relative risk; CrI, credible interval.
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Third, there was noticeable surplus of cases in
individuals aged between 20 and 40 years, which
were outside the 95% CrI of the simple cross-
immunity model (Fig. 2a–e). Some of this variation
could be explained when we used a model with age-
speciﬁc H5N1 exposure risk (Fig. 2f–j), suggesting
that H5N1 infection patterns depended on addi-
tional variables besides population demography and
cross-immunity.
There are some limitations to our analysis. We used
a simple model of infection, treating each country as a
single population. In reality, there was likely to be re-
gional variation in disease incidence [3, 4]. Further, we
did not consider potential differences in reporting rate
with age. Such differences could affect the number of
reported spillover events, and hence explain some of
the age-speciﬁc variation not captured by the model
(Fig. 2).
As there were limited data available about the age-
speciﬁc risk of H5N1 exposure, we used a simple step
function to represent relative risk in different groups.
This resulted in several additional model parameters,
reducing model performance under BIC. Future em-
pirical studies could help address this issue. By collect-
ing data on factors that could affect H5N1 exposure
risk, such as contact with animals, it would be possible
to parameterize the age-dependent exposure risk di-
rectly. Such data would reduce model complexity,
and could potentially provide a parsimonious expla-
nation for the variation in inﬂuenza A(H5N1) infec-
tion patterns not captured by our model.
We estimated that the annual probability of gaining
cross-immunity to H5N1 as a result of H1N1 infection
was 0·04–0·06. A cohort study of 1793 participants
in Vietnam reported 196 serologically conﬁrmed
inﬂuenza A(H1N1) infections over three seasons be-
tween 2007–2010 [13]. This suggests the average
annual risk of H1N1 infection was 0·11 (95% CrI
0·09–0·12). If cross-immunity against H5N1 comes
only from prior H1N1 infection, our estimates there-
fore suggest that infection with H1N1 has a 0·36–
0·55 probability of conferring protection to H5N1.
However, there is evidence that some individuals in
Southeast Asia might have also had inﬂuenza A
H5-speciﬁc antibodies from prior exposure to H5N1
[14]. These antibodies, or antibodies from prior ex-
posure to other related viruses, could have contributed
to cross-immunity as well. With population-level data
on prior exposure to different subtypes, it might be
possible to separate the relative contributions to im-
munity made by each subtype, and obtain better
estimates for cross-immunity between inﬂuenza A
(H1N1) and A(H5N1).
Our results suggest that cross-immunity and de-
mography can explain several aspects of observed
patterns of inﬂuenza A(H5N1) infection. Further inves-
tigation into cross-reaction between inﬂuenza subtypes
could aid the interpretation of other infection data.
For instance, cross-immunity might help explain why
the age distribution of cases for H5N1 is much younger
than for H7N9 [3, 15]: H5N1 shares a neuraminidase
subtype with seasonal strains whereas H7N9 does not.
In some instances, it might be necessary to consider
both inter- and intra-subtyptic cross-immunity. There
are concerns about the potential re-emergence of
inﬂuenza A(H2N2) [16], a subtype that circulated in
human populations between 1957 and 1968. However,
older age groups might have immunity to H2N2 and/
or cross-immunity from prior infection with A(H3N2).
Such cross-immunity is likely to inﬂuence inﬂuenza
virus transmission [9]. When assessing potential con-
trol measures against emerging pathogens, is often
assumed that the host population is fully susceptible
to infection [17, 18]. This is the case for entirely
novel pathogens, but for infections such as inﬂuenza
A(H5N1), our results suggest it is important to
account for potential cross-immunity when evaluating
the virus’s ability to spread in a human population.
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